MedTrace Logo

Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.

NCT05878041 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-03-21

No results posted yet for this study

Summary

Peripartum cardiomyopathy (PPCM) is a rare, severe and potentially life-threatening disorder of largely unknown etiology and pathophysiology, with unexplained geographical differences and heterogeneous presentation. Investigators hypothesize that a network-based multidisciplinary strategy integrating clinical and molecular phenotyping of PPCM patients might anticipate diagnosis, optimize treatments, and identify novel mechanisms to achieve the unmet goal of personalized medicine.

Conditions

  • Peripartum Cardiomyopathy

Interventions

DIAGNOSTIC_TEST

Molecular and genetic screening

Molecular and genetic screening

Sponsors & Collaborators

  • San Raffaele University Hospital, Italy

    collaborator OTHER

  • San Giuseppe Moscati Hospital

    collaborator OTHER

  • Federico II University

    lead OTHER

Principal Investigators

  • Cinzia Perrino, MD pHD · Federico II University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-21
Primary Completion
2025-02-19
Completion
2026-05-19

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05878041 on ClinicalTrials.gov